Repositorio Dspace

Does Employee Care Trigger Innovation Under a Healthy and Safe Working Environment? Evidence from the Pharmaceutical Industry in China

Mostrar el registro sencillo del ítem

dc.rights.license CC BY eng
dc.contributor.author Yang, Ming Hui cze
dc.contributor.author Lin, Qian cze
dc.contributor.author Marešová, Petra cze
dc.date.accessioned 2026-07-21T06:17:33Z
dc.date.available 2026-07-21T06:17:33Z
dc.date.issued 2021 eng
dc.identifier.issn 2227-9032 eng
dc.identifier.uri http://hdl.handle.net/20.500.12603/2733
dc.description.abstract Sustainability of the workforce becomes a crucial issue, of which responsible care for employees can increase job satisfaction and human capital that impact corporate ability to absorb and generate new knowledge. Firms are obligated to provide a healthy and safe working environment for their employees, but it may in turn hinder innovation due to rigid and structured institutional regulations. Drawing on data of 308 China's pharmaceutical firms from 2010 to 2017, we investigated whether employee care can trigger innovation under corporate adoption of the occupational health and safety management system (OHSMS). Our results suggest that both employee care and OHSMS adoption have a positive impact on innovation. Moreover, the positive relationship between employee care and innovation was more pronounced in firms that had adopted the OHSMS certification. These findings are valuable to policymakers and corporate managers in emerging economies through corroborating the important role of workforce sustainability in facilitating firm innovation. eng
dc.format p. "Article Number: 194" eng
dc.language.iso eng eng
dc.publisher MDPI eng
dc.relation.ispartof HEALTHCARE, volume 9, issue: 2 eng
dc.subject employee care eng
dc.subject workforce sustainability eng
dc.subject occupational health and safety eng
dc.subject innovation eng
dc.subject pharmaceutical industry eng
dc.title Does Employee Care Trigger Innovation Under a Healthy and Safe Working Environment? Evidence from the Pharmaceutical Industry in China eng
dc.type article eng
dc.identifier.obd 43877561 eng
dc.identifier.wos 000622607300001 eng
dc.identifier.doi 10.3390/healthcare9020194 eng
dc.publicationstatus postprint eng
dc.peerreviewed yes eng
dc.source.url https://www.mdpi.com/2227-9032/9/2/194 cze
dc.relation.publisherversion https://www.mdpi.com/2227-9032/9/2/194 eng
dc.rights.access Open Access eng


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Buscar en DSpace


Listar

Mi cuenta